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Background: Establishing highly productive clonal cell lines with constant productivity over 2–3 months of continuous
culture remains a tedious task requiring the screening of tens of thousands of clonal colonies. In addition, long-term
cultivation of many candidate lines derived in the absence of drug selection pressure is necessary. Expression vectors
based on the elongation factor-1 alpha (EEF1A) gene and the dihydrofolate reductase (DHFR) selection marker (with
separate promoters) can be used to obtain highly productive populations of stably transfected cells in the selection
medium, but they have not been tested for their ability to support target gene amplification under gradually increasing
methotrexate pressure.
Results: We have modified EEF1A-based vectors by linking the DHFR selection marker to the target gene in the
bicistronic RNA, shortening the overall plasmid size, and adding an Epstein-Barr virus terminal repeat fragment
(EBVTR) element. Presence of the EBVTR element increased the rate of stable transfection by the plasmid by 24
times that of the EBVTR-minus control and improved the rate of methotrexate-driven gene amplification. The mean
expression level of the enhanced green fluorescent protein (eGFP) used herein as a model protein, increased up to
eight-fold using a single round of amplification in the case of adherent colonies formation and up to 4.5-fold in
the case of suspension polyclonal cultures. Several eGFP-expressing cell populations produced using vectors with
antibiotic resistance markers instead of the DHFR marker were compared with each other. Stable transfection of
Chinese hamster ovary (CHO) DG44 cells by the p1.2-Hygro-eGFP plasmid (containing a hygromycin resistance marker)
generated highest eGFP expression levels of up to 8.9% of the total cytoplasmic protein, with less than 5% of the cell
population being eGFP-negative.
Conclusions: The p1.1 vector was very effective for stable transfection of CHO cells and capable of rapid MTX-driven
target gene amplification, while p1.2-Hygro achieved similar eGFP expression levels as p1.1. The set of vectors we have
developed should speed-up the process of generating highly productive clonal cell lines while substantially decreasing
the associated experimental effort.
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Most of the proteins currently employed for therapeutic
use are produced by stably transfected mammalian cells,
of which the most popular is the Chinese hamster ovary
(CHO) cell line. Establishing highly productive clonal
cell lines that exhibit constant productivity over a 2–3
month period of continuous culture remains a tedious
task, requiring tens of thousands of clonal colonies to be
screened, followed by the long-term cultivation of candi-
date lines in the absence of an appropriate selection
pressure. Generally, the expression levels of a target gene
may be increased by its amplification in the genome [1],
which is usually achieved by linking the target gene to
the murine dihydrofolate reductase (DHFR) gene with
stepwise increases in the concentration of the DHFR in-
hibitor, methotrexate (MTX), in the selection medium.
Target gene amplification is a time-consuming process,
resulting in cell populations that often contain unstable
clones, and in the absence of an appropriate selection
pressure, reduced production levels. The probability of
obtaining a highly productive clonal cell line can be in-
creased significantly by utilizing plasmids based on non-
coding parts of the elongation factor-1 alpha gene (EEF1A)
from Chinese hamster, as described by Running Deer and
Allison [2]. Expression vector pDEF38, introduced by these
authors, differs significantly from the widely employed vec-
tors with the core promoter of the human ortholog elong-
ation factor 1 alpha gene (EF1a). EEF1A-based expression
vector includes 4.1 kb upstream and 4.2 kb downstream
flanking areas of the EEF1A gene, so the ORF of the of the
target gene replaces the coding exons of the elongation fac-
tor 1 alpha protein in the natural EEF1A gene, mimicking
with all possible accuracy the structure of the natural gene
in the resulting expression plasmid. It was shown that
presence of both flanking areas in the EEF1A-based vectors
results in the 6- to 35- fold increase of the average expres-
sion level comparing to commercial vectors with CMV or
EF1alpha promoters. Removal of the downstream flanking
area from the expression vector resulted in the 4-fold drop
in the expression level.
Original expression vector pDEF38 contained the DHFR
selection marker with a separate SV40 promoter and
was not tested for its ability to support target gene
amplification under gradually increasing MTX pres-
sure. DHFR-compatible vectors, bearing the neomycin
resistance gene instead of the DHFR gene, were also
described in the same work. Existing EEF1A-based
vectors, despite their high promoter strength and their
long-term production level stability, do not accommo-
date very large plasmid sizes. Consequently, this can re-
sult in low-level genome integration and inability to
maintain the target gene amplification step, possibly as a
result of vector fragmentation and autonomous amplifi-
cation of the DHFR-coding area.Since EEF1A-based vectors are much longer than CMV-
based vectors, they are expected to have lower transfec-
tion efficiency and, subsequently, lower numbers of sta-
bly transfected cells. It was shown, that the insertion
the concatemer fragment of the Epstein-Barr virus ter-
minal repeats (EBVTR) [3,4] in the expression vectors
increase the rate of stably transfected colonies forma-
tion by five to ten fold [5]. The molecular mechanism
of this effect is poorly understood. It is known that
G-rich repeats in the EBVTR bind to the cellular protein
terminal repeat binding protein (TRBP) [3] and at least
two binding sites of TRBP were identified in the repeti-
tive cellular DNA [6]. EBVTR areas are involved in the
integration of the Epstein-Barr virus into the chromo-
somal DNA [7]. EBV-infected cells may harbour the virus
in the chromosome-integrated form, as the independ-
ently replicating episome or the mixture of both forms
[8]. Region of the EBV, called oriP, maintains the epi-
somal replication of the EBV genome, interacts with the
EBV-encoded nuclear antigen-1 (EBNA-1) and allows
EBV plasmids to separate in mitosis through binding to
chromosomes [9]. EBVTR concatemer used for en-
hancement of expression plasmids, however, contains
no sequences from the oriP region and no DNA frag-
ments with significant homology toward oriP region,
so the EBNA-1 – mediated persistence of the EBVTR-
containing plasmid as the episome in the transfected
cells is highly unlikely.
We hypothesized that significant improvements to
EEF1A-based vectors might be achieved by: 1) inserting
the EBVTR element outside of the EEF1A flanking
DNA; 2) linking the DHFR open reading frame to the
target gene by the internal ribosome entry site (IRES)
thereby preventing the possibility of separate amplifi-
cation of the selection marker; 3) reducing of the
length of the backbone DNA, which is necessary for
maintaining the plasmid in the bacterial host. Similar
improvements might be applied to DHFR-compatible
EEF1A-based vectors used for monocistronic expres-
sion of a target gene; in this case by placing the anti-
biotic resistance genes outside the context of the
non-coding parts of the elongation factor 1 alpha gene,
which might decrease genetic linkage between the se-
lection marker and the target gene.
Here, we report on the functional properties of EEF1A-
based plasmid vectors for bicistronic and monocistronic
expression. We also describe the corresponding methods
for obtaining highly productive and stable cell lines that
maintain constant productivity levels after genome ampli-
fication of the integrated plasmid, utilizing the DHFR-
negative cell line CHO DG44 [10,11]. In addition, we
used the enhanced green fluorescent protein (eGFP) as
a model target protein, and show eGFP accumulation
inside CHO cells.
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Molecular cloning
The sequences of the primers used for cloning expres-
sion plasmids are shown in Additional file 1: Table S1.
The backbone vector, pBL-2, was obtained by two stages
of inverted PCR using long adapter primers and the
pUC18 plasmid as a template. Non-functional parts of
the plasmid including the pLac promoter and the LacZ
gene were removed. Inverted PCR was performed as de-
scribed previously [12]. Oligonucleotides and PCR re-
agents were from Evrogen, JSC (Moscow, Russia). PCR
products were purified from 1% agarose gels by the
Wizard SV Gel and PCR Clean-Up System (Promega,
Madison, WI). T4 polynucleotide kinase and MalI re-
striction endonuclease (Sibenzyme, Novosibirsk, Russia)
were used. T4 DNA ligase (Fermentas, Vilnius, Lithuania)
was used for inverted PCR product circularization. The
Escherichia coli TOP10 strain (Invitrogen, Carlsbad, CA)
was used for cloning. Plasmids were isolated with a
GeneJet Plasmid Purification Kit (Fermentas, Vilnius,
Lithuania).
The pAL-EBV plasmid, containing a fragment of a
concatemer of EBV terminal repeats, as described previ-
ously [5] and nearly undistinguishable from the human
herpes virus 4 strain K4123-MiEBV sequence [GenBank:
KC440852.1] was made from synthetic oligonucleo-
tides cloned into a pAL-TA (Evrogen) vector. The ORF
encoding mouse DHFR was obtained by PCR using
pOptivec-TOPO linearized vector (Invitrogen) as a tem-
plate. The fragment encoding the attenuated encephalo-
myocarditis virus (EMCV) IRES was obtained from the
pOptivec-circ plasmid (self-ligated pOptivec-TOPO) by
restriction. These fragments were cloned into the pBL-2
plasmid via assembly of two different intermediate con-
structs, PBL-2-ID and PBL-2-ID-EBV. DNA modification
enzymes for routine molecular cloning were obtained
from Fermentas or Sibenzyme.
Construction of p1.1 vectors
Fragments corresponding to the upstream and down-
stream flanking regions (8532–12603 and 14545–18794
sequences of [GenBank:AY188393]) of the CHO elong-
ation factor 1 gene were obtained by PCR using CHO
DG44 cell (Invitrogen) genomic DNA as a template. The
modular assembly cloning technique used herein is de-
scribed in detail elsewhere [13].
Assembled CHO genomic regions were cloned into the
intermediate plasmids, PBL-2-ID and PBL-2-ID-EBV,
resulting in p1.1(EBVTR-) and p1.1 expression vectors,
respectively (Figure 1).
Construction of p1.2 vectors
p1.2-Mono, the intermediate backbone plasmid for ex-
pression vectors bearing antibiotic resistance genes wasobtained by removal of the region containing the EMCV
IRES and the DHFR ORF from the p1.1 expression vec-
tor. Plasmid pAL-3CH123, containing first three mod-
ules of the downstream flanking region of the EEF1A
was used as the source of the donor DNA insert frag-
ment, replacing the deleted IRES and DHFR area, so
both flanking regions of the EEF1A remained unaltered
(Figure 2). Antibiotic resistance genes and the SV40 pro-
moter and terminator regions were obtained by amplifi-
cation with adaptor primers, using pcDNA3.1/Hygro,
pcDNA3.1(+), and self-ligated pcDNA4/HisMax-TOPO
(Invitrogen) as PCR templates. Antibiotic resistance
cassettes were sub-cloned into T-vectors and then trans-
ferred into the p1.2-Mono backbone by restriction-
ligation resulting in p1.2-Hygro, p1.2-Neo and p1.2-Zeo.
A DNA fragment encoding eGFP and a consensus
Kozak sequence (GCCGCCATGG) [14] was obtained by
PCR with adaptor primers and the pEGFP-C2 plasmid
(Clontech, Mountain View, CA) as a template and then
cloned into the polylinker area of p1.1 and p1.2 vectors,
thereby resulting in p1.1(EBVTR-)eGFP, p1.1eGFP, p1.2-
HygroeGFP, p1.2-NeoeGFP and p1.2-ZeoeGFP expres-
sion plasmids.
Purified plasmids for transfection and the control
plasmid pEGFP-N2 (Clontech) were prepared using an
EndoFree Plasmid Maxi Kit (Qiagen, Valencia, CA). For
stable cell line generation all plasmids except p1.2-Hygro-
eGFP were linearized by restriction with PvuI by cut-
ting inside the ampicillin resistance gene bla sequence.
The plasmid p1.2-HygroeGFP was restricted with BspHI,
which introduced two breaks near the bla gene.
Cell culture
A DHFR-negative CHO DG44 cell line (Invitrogen)
was cultured in shaking flasks in the chemically de-
fined medium, CD DG44 (Invitrogen), supplemented with
0.18% Pluronic F-68 (Invitrogen) and 4 mM L-glutamine
(Invitrogen). The cells were passaged 24 h before transfec-
tion. For direct colony generation in 96-well culture plates,
transfection was performed using Fugene HD reagent
(Promega), containing 60 μg of DNA and 180 μl of the
reagent per 15 millions of cells in 30 ml of the above
medium. Plasmids p1.2 were transfected by electro-
poration in Gene Pulser Electroporation Buffer (Bio-Rad,
Hercules, CA) using a cuvette with a 4 mm gap with 7.5
million cells and 15 μg of linearized DNA for each transfec-
tion. Cells were counted by trypan blue exclusion and fluor-
escence microscopy at 48 h post-transfection. For direct
generation of colonies, transiently transfected cell cultures
were transferred into CHO-A culture medium (Invitrogen)
lacking hypoxanthine and thymidine (HT), and seeded at
5000 cells/well in the culture plates. Cells were grown un-
disturbed for 14 days and inspected by fluorescence mi-
croscopy. The medium was changed and the plates were
Figure 1 Map of the p1.1 plasmid vector and the cloning scheme for p1.1-based plasmids. A. Plasmid map. UFR: upstream flanking region
of the EEF1A gene; DFR: downstream flanking region; PL: polylinker region; pA: polyadenylation signal; bla – ampicillin resistance gene; bla
prom – promoter of the ampicillin resistance gene. B. Cloning scheme for p1.1-based plasmids. Generation of cloning inserts by PCR with
adaptor primers is depicted by dashed lines; generation of cloning inserts by restriction is depicted by solid lines. EBV F1-6: corresponding
synthetic fragments of the EBVTR element. 5CH F1-6: corresponding fragments of the upstream flanking region of the EEF1A gene; 3CH F1-6:
corresponding fragments of the downstream flanking region of the EEF1A gene.
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the wells containing colonies became confluent.
To generate stably transfected cell populations using
p1.1eGFP and p1.1(EBVTR-)eGFP plasmids, transiently
transfected cultures were transferred to OptiCHO medium
(Invitrogen) lacking HT, and thereafter cultivated in shak-
ing flasks with medium exchange every 3 days until the cell
viability increased to 85% (approximately 22–27 days of
cultivation).
MTX-driven target gene amplification in culture plates
was performed by seeding the cells from stably transfectedFigure 2 Map of the p1.2-Hygro plasmid vector and the cloning sche
region of the EEF1A gene; DFR: downstream flanking region; Pl: polylinker
from the SV40 virus. B. Cloning scheme for p1.2-based plasmids.cell populations into 96-well culture plates at a density of
5000 cells/well in the CHO-A culture medium, supple-
mented with 0, 50, 100, 200, 400 or 800 nM MTX. Three
plates were used for each concentration of MTX. The cells
were grown undisturbed for 14 days, after which the plates
were inspected by microscopy and the culture medium
was changed every 4 days until the first 10% of wells in
each plate became confluent. Plates were screened again by
fluorescence microscopy, and cells from the 16 brightest
wells from each plate were transferred into a 48-well plate,
grown to confluence, and then transferred into 24-wellme for p1.2-based plasmids. A. Plasmid map. UFR: upstream flanking
region; SV40 prom and SV40 PA: promoter and polyadenylation signal
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tached to the surface of the plates too tightly for dislodging
by pipetting were discarded. Cells from the eight brightest
wells for each MTX concentration were dislodged from
their plates, lysed as described below, and then used to de-
termine eGFP levels. Six randomly picked colonies, ob-
tained in the presence of 400 and 800 nM MTX, were
transferred into a 6-well plate and grown with shaking in
OptiCHO medium with passages made every three days
for 60 days. Samples for eGFP level determination were
collected every second passage.
Target gene amplification for polyclonal cell popula-
tions was performed for the suspension culture of CHO
DG44 cells, stably transfected by the p1.1eGFP plasmid
in presence of 50 nM MTX, as described above. Concen-
tration of the MTX in the culture medium was increased
by two-fold steps, each after two consecutive passages,
until the cell viability decreased below 85%. Resulting
culture, obtained in presence of 0.8 μM MTX, was split
into four flasks, supplemented by 0.8; 1.6; 3.2; 6.4 μM
MTX and cultured until the cell viability returned to at
least 85% (7–12 days).
Generation of polyclonal cell populations involving
transfected p1.2 plasmids were performed by seeding
transiently transfected cells in 6-well culture plates,
using 1 million of viable cells per well in 5 ml of DG44
medium, supplemented with the corresponding anti-
biotic, or 5 ml of OptiCHO medium with 200 nM MTX
for control transfections using p1.1 plasmids. The con-
centrations of the antibiotics used are shown in Figure 3.
Plates were cultivated with shaking until the cell viability
returned to at least 85% (20 days), after which the
medium was changed every 4 days.
Determination of eGFP concentrations in cell lysates
Cell culture samples containing approximately one million
of cells were centrifuged and the cell pellets were resus-
pended in phosphate buffered saline and recentrifuged.
The washed cell pellets were resuspended in 0.1 ml of lysis
solution containing 150 mM NaCl, 50 mM Tris–HCl at
pH 7.5, 1% Triton X-100, a protease inhibitor cocktail
(Sigma, St. Louis, MO), and then incubated for 30 min on
ice with stirring. Cell debris was removed by centri-
fugation. The concentration of eGFP in the lysate from
the H-4 cell population (Figure 3) was measured by spec-
trophotometry at a wavelength of 488 nm using a molar
extinction coefficient of 55,000 M−1 · cm−1 and an eGFP
molecular weight of 32.7 kDa [15]. The fluorescence in-
tensity of eGFP in all of the lysates was measured along
with the serially diluted calibration samples, which were
prepared from the H-4 lysate containing a known con-
centration of eGFP. Total protein concentration in the ly-
sates was measured by the Bradford method with bovine
serum albumin as a standard.FACS analysis and quantitative PCR
Undiluted cell culture samples were subject to FACS FC
500 (Beckman Coulter, Krefeld, Germany) analysis at an
emission at 488 nm and detection through a 530/40-nm
bandpass filter. At least 10,000 individual cells were
counted for each sample analysed. Quantitative PCR
analysis of the expression plasmid copy numbers in the
genomes of stably transfected cells was performed using
an iCycler iQ thermocycler (Bio-Rad) and qPCRmix-HS
SYBR (Evrogen) reaction mixture with the primers
shown in Additional file 1: Table S2. The highly purified
p1.1eGFP plasmid was used as a quantity calibrator
using five different concentrations for each determin-
ation performed in triplicate. PCR was performed three
times with three to four replicates for each sample. Gen-
omic DNA was extracted from cells with a Genomic
DNA Purification Kit (Fermentas) and quantified using a
Qubit fluorometer (Invitrogen) and the dsDNA HS kit
(Invitrogen). Quantity calibrator plasmid was used as the
external standard for the quantification of genomic DNA
samples by fluorometry.
Results and discussion
Construction of expression plasmids
Since the transfection efficiency and, probably, the gen-
ome integration rate of an expression plasmid is in-
versely proportional to its size [16], we made a minimal
backbone plasmid by eliminating most of the unneces-
sary elements from the pUC18 plasmid. The resulting
plasmid, pBL-2, lacks the f1 origin of replication, and
the bacterial promoter of the LacZ gene along with the
LacZ ORF itself and some flanking DNA regions. Over-
all, the resulting plasmid length decreased some 600 bp
from 2686 to 2032 bp.
The upstream and downstream regions of the EEF1A
gene were obtained from CHO DG44 cell genomic DNA
using the modular assembly cloning technique described
previously [13]. A concatemer of terminal repeats from
the Epstein-Barr virus (EBVTR) [3,4] was assembled
from synthetic oligonucleotides using the same tech-
nique and was inserted along with the IRES from the en-
cephalomyocarditis virus and the murine DHFR open
reading frame into the pBL-2 vector. Cloning the up-
stream and downstream flanking areas of the EEF1A
gene into the pBL-2-ID-EBV plasmid resulted in the ex-
pression vector p1.1 (Figure 1). A control vector, lacking
the EBVTR fragment, was assembled similarly and is
denoted here as p1.1(EBVTR-). The p1.1 plasmid was
approximately 1.5 kbp shorter than the original EEF1A-
based plasmid, pDEF38, despite addition of the EBVTR
fragment. The eGFP ORF with the synthetic consensus
Kozak sequence [14] was cloned into both vectors and
the resulting plasmids p1.1eGFP and p1.1(EBVTR-)eGFP
were used for CHO cell transfections.
Figure 3 Properties of the cell populations stably transfected by p1.2-based plasmids under various drug selection stringencies. DG44:
untransfected CHO DG44 cells; p1.1: cells stably transfected by the p1.1eGFP plasmid and selected in the presence of 200 nM MTX; p1.1(EBVTR-):
transfection by the p1.1(EBVTR-)eGFP plasmid using the same conditions. A. Level of intracellular eGFP in cell populations. Error bars indicate
the standard deviation, n = 2. B. Proportion of eGFP-negative cell populations measured by FACS. C. Number of copies of genome-integrated
plasmids measured by Q-PCR. Amplicons are located inside the eGFP ORF and one representative value experiment from three independent
measurements is shown. Error bars represents standard deviations, n = 3-4. The apparent level of the eGFP ORF DNA for the untransfected
CHO DG44 cells is below 0.1 copies per one haploid genome. D. Codes for the different cell populations and the concentrations of
antibiotics employed.
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p1.1-based plasmids
Transient transfection of the DHFR-deficient CHO DG44
cells resulted in significantly decreased transfection effi-
ciencies for both of the EEF1A-based plasmids relative
to the cytomegalovirus (CMV)- promoter-based 4700 bp
pEGFP-N2 plasmid, and approximately the same transfec-
tion efficiencies and eGFP expression levels for plasmids
with or without the EBVTR element (Table 1).
At the same time, stable integration rate (or rate of
establishment of stable episomal maintenance) of the
p1.1eGFP plasmid was 24 times higher than that ofthe p1.1(EBVTR-)eGFP control plasmid in the selec-
tion medium lacking both HT and MTX (Table 2),
clearly indicating that the EBVTR element was active
in the very large expression plasmid. Transfection and
selection of stably transformed CHO DG44 cells by
the p1.1eGFP plasmid was repeated with the selec-
tion medium supplemented with 50 nM MTX. In this
case, the eGFP expression level increased twice for
the ten most productive wells (Figure 4A). Thus, the
p1.1 plasmid is suitable for creation of stably trans-
fected cell clones or populations under variable selection
stringencies.
Table 1 Properties of the transiently transfected cells used
in this study
Plasmid name pEGFP-N2 p1.1eGFP p1.1(EBVTR-)eGFP




Viable cells 86% 83% 84%
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Since the EBVTR element was effective at increasing
the incidence of stable transfection, we tested its ability
to speed up the transgene amplification process. Poly-
clonal populations of CHO DG44 cells, transfected by
p1.1eGFP and p1.1(EBVTR-)eGFP plasmids and selected
for stable integration by suspension cultivation in the
absence of MTX and HT, were seeded in the 96-well
culture plates in the presence of 0–800 nM MTX and
grown undisturbed until visible colonies developed. For
the p1.1(EBVTR-)eGFP plasmid lacking the EBVTR
element, no viable cell colonies were obtained in the
presence of 200, 400 and 800 nM MTX. The eGFP ex-
pression levels of the highest expressing colonies, ob-
tained in the presence of 0 and 100 nM MTX, was in
the same range as the colonies obtained by direct plating
of transiently transfected cells in the absence of MTX
(data not shown). In the case of the p1.1-eGFP plasmid,
multiple colonies were obtained for all of the concentra-
tions of MTX tested. After visual screening by fluores-
cence microscopy and expansion, the eight brightest
colonies for each concentration of MTX employed were
grown to confluency in 24-well culture plates. The rela-
tive eGFP expression levels for these colonies (Figure 4B)
was approximately 8 times higher when cultivated with
800 nM MTX, and approximately 2 times higher when
cultivated with 400 nM MTX, compared with cultivation
without MTX. Six randomly chosen colonies, obtained
in the presence of 400 and 800 nM MTX, were scaled
up, re-adapted to suspension culture and cultivated for
60 days. No substantial decay in the eGFP expression
level was detected for each colony (data not shown).
Thus, the p1.1 vector is suitable for target gene amplifi-
cation in the presence of MTX. The resulting cell clonesTable 2 Colony formation efficiency for p1.1eGFP and
p1.1(EBVTR-)eGFP plasmids
Plasmid name p1.1eGFP p1.1(EBVTR-)eGFP
Total number of colonies in 10
culture plates
2342 95
eGFP-expressing colonies in 10
culture plates and their proportions
2093 (89.4%) 52 (54.7%)
Fluorescence intensity of the
brightest well, RFU/50 cells
210 45.1are sufficiently stable for cell bank generation and subse-
quent large-scale cultivation.
Target gene amplification process was also tested for
polyclonal cell population, obtained by the primary se-
lection in the presence of 50 nM MTX. Sequential
addition of MTX from 100 nM to 400 nM gave no de-
crease in cell viability, eGFP level was also constant (data
not shown). Further addition of 0.8 – 6.4 μM of MTX,
performed in one step for multiple culture flasks, re-
sulted in the concentration-dependent increase of eGFP
content (Figure 4C), peaking at 9% of the total protein
in the case of 6.4 μM of MTX. Analysis of the copy
numbers of the integrated plasmids using quantitative
PCR (Figure 4D) showed that higher MTX level and
higher eGFP content correspond to higher copy number
of the integrated plasmid. Hereby, the vector p1.1 is suit-
able for obtaining highly productive cell populations or
clones by direct clone selection in culture plates in the
presence of MTX or by the multi-step target gene ampli-
fication in the suspension culture.
Polyclonal cell populations stably transfected by p1.2
plasmids
Heterologous expression of a functionally active target
protein often requires co-expression of a small number
of protein processing enzymes. For example, the blood
clotting factor IX expression systems used with CHO or
BHK cells rely on co-expression of the signal protease
PACE/furin [17] and the vitamin-K recharging enzyme,
VKORC1 [18]. Generally, the expression levels of such
“helper” proteins should be lower than that of the target
protein, but of comparable magnitude. If the target pro-
tein is coded by a plasmid bearing a DHFR selection
marker, helper proteins may be coded by plasmids with
the same structure, but bearing antibiotic resistance
markers. We have tested resistance markers for three
widely used antibiotics, G418 (a neomycin analogue),
zeocin, and hygromycin, in the EEF1A-based expression
vector, which was modified by removing the IRES frag-
ment and the DHFR open reading frame from the p1.1
plasmid, and insertion of the corresponding antibiotic
resistance genes outside of the EEF1A gene flanking
areas and controlled by a separate SV40 promoter. The
resulting vectors, denoted p1.2-Neo, p1.2-Zeo, and p1.2-
Hygro, were used for insertion of the eGFP protein ORF.
All three resulting plasmids showed similar transient
transfection efficiencies in CHO DG44 cells (19–24% by
electroporation), and the resulting cell populations were
used to generate stably transfected cell populations in
the suspension culture under variable selection pressures
for each antibiotic used. The control plasmids p1.1eGFP
and p1.1(EBVTR-)eGFP were transfected using the same
procedure and stably transfected cell populations were
generated by suspension cultivation in the presence of
Figure 4 eGFP-expressing cell colonies obtained by elevated selection pressure and by targeted gene amplification. Red bars: mean
eGFP levels for sets of cell colonies analysed. Concentrations represent final concentrations of MTX used. A. eGFP levels for 10 colonies obtained
in the absence of MTX and in the presence of 50 nM MTX, colonies were obtained by the direct plating of transiently transfected cells. B. eGFP
levels for 8 colonies obtained by growth in the presence of various MTX concentrations. Polyclonal stably transfected cell population was
used for plating. C. Level of intracellular eGFP in polyclonal cell populations, obtained by primary selection in presence of 50 nM MTX and
subsequent amplification in presence of various concentrations of MTX. Error bars indicate the standard deviation, n = 2. D. Number of copies of
genome-integrated plasmids measured by Q-PCR for populations from panel C. Amplicons are located inside the eGFP ORF and one representative
value experiment from three independent measurements is shown. Error bars represents standard deviations, n = 3.
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to determine the proportion of eGFP-expressing cells
and eGFP levels in cell lysates (Figure 3). We found that
for all three selection markers at all levels of drug selec-
tion pressure the resulting cell populations contained
more than 75% of eGFP-positive cells. For the hygromy-
cin and MTX resistance markers, less than 5% of the
cells were eGFP-negative. The level of eGFP in the cell
lysates was maximal for hygromycin selection, peaking as
8.9% of the total cellular protein with 0.5 mg/ml of hygro-
mycin. In contrast, eGFP levels in the polyclonal cell
populations obtained from transfection with p1.1eGFP
or p1.1(EBVTR-)eGFP were much lower at 1.9% and
1.0%, respectively; however, eGFP expression levels for
the p1.1 vector could potentially increase by eight-fold
using the MTX-driven target gene amplification
described above.
We also measured the intracellular eGFP distribution
in polyclonal cell populations using FACS (Figure 5).
Virtually no cells were eGFP-negative with DHFR and
hygromycin selection markers, whereas with the neomy-
cin resistance gene the level of eGFP-negative cells was
inversely proportional to the concentration of G418used. The mean eGFP level for the upper 10% of the
eGFP-positive cells was not dependent on the antibiotic
concentration for neomycin and zeocin selection, whereas
with hygromycin selection the mean eGFP level was
higher at higher antibiotic concentrations.
Analysis of the copy numbers of the genome-integrated
plasmids using quantitative PCR revealed that the p1.2-
Hyg-eGFP plasmid generated the maximum number of
inserts, correlating with the highest expression level of
eGFP. While the p1.2-Zeo-eGFP plasmid exhibited higher
eGFP expression levels than p1.2-Neo-eGFP, it was present
at half the copy number. In the case of plasmids containing
the DHFR selection marker, the presence of the EBVTR
element resulted in higher eGFP expression levels at lower
numbers of genome inserts; this probably indicates that
EBVTR drives integration events in areas of the genome
that are transcriptionally active.
Conclusions
Creation of mammalian cell lines that express high levels
of recombinant protein and maintain stable production
levels over several months of cultivation is still a very time-
consuming and labour-intensive process. Introduction of
Figure 5 Distribution of the eGFP expression levels in cell populations as determined by FACS analysis. Codes for the corresponding cell
populations are the same as in Figure 3. First number after the cell population code: mean level of eGFP in the sample; second number: mean
level of eGFP in the upper 10% of the eGFP-positive cells.
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enabled smaller numbers of cell clones to be screened
and evaluated by increasing the mean level of target
protein expression. We have modified existing EEF1A-
based vectors by linking the DHFR selection marker
and target gene in the bicistronic RNA, shortening the
overall plasmid size, and adding an EBVTR element.
The presence of an EBVTR element in the resulting
p1.1 vector increased the stable transfection rate by a
factor of 24, and increased the target protein expression
level by eight-fold using a single round of MTX-driventarget gene amplification. Two consecutive rounds of
MTX-driven amplification, performed for suspension
culture, resulted in the polyclonal cell population with
the eGFP expression level comprising 9.0% of the total
cytoplasmic protein. Compatible vectors bearing anti-
biotic resistance markers instead of the DHFR gene
were created and found to be approximately equal to
the DHFR-based vector for generation of highly pro-
ductive cell populations. We found that the EEF1A-based
vector, p1.2-Hygro, containing the hygromycin selection
marker, allowed direct generation of a polyclonal cell
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http://www.biomedcentral.com/1472-6750/14/56population that was nearly devoid of eGFP-negative cells,
while eGFP expression comprised up to 8.9% of the total
cytoplasmic protein. This level of eGFP expression corre-
sponds to only 30 copies of the target gene per single
haploid genome, in contrast to CMV-based vectors that
have thousands of copies per genome in highly pro-
ductive lines [19]. The set of vectors developed herein
allows generation of highly productive and stable cell
clones with limited effort and such vectors may be
employed to create cell lines for production of biosimi-
lar pharmaceuticals. p1.1 or p1.2-based plasmids, stably
transfected into polyclonal cell populations expressing
large quantities of target proteins at a scale of 4–6*107
cells, can be generated in less than one month by sim-
ple periodic passage of a culture from a shaking flask.
This technique may be useful for obtaining milligram
quantities of mutants of a protein of interest or for
evaluation of several mAb clones. Cells from these
polyclonal populations may be also used for direct devel-
opment of industrially applicable clonal cell lines by lim-
iting dilution.
Additional file
Additional file 1: Primer sequences used for cloning and
sequencing the p 1.1 and p 1.2 expression vectors.
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